Condition: Asthma · Sponsor: Eli Lilly and Company
The purpose of this study is to assess the safety and efficacy of brenipatide at different dose levels compared with placebo in participants with moderate-to-severe asthma. Study participation will last approximately 65 weeks, including screening, treatment, and follow-up periods.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| AMR Clinical | Tempe, Arizona, United States | Recruiting |
| NewportNativeMD, Inc. | Newport Beach, California, United States | Recruiting |
| California Medical Research Associates | Northridge, California, United States | Recruiting |
| Peninsula Research Associates | Rolling Hills Estates, California, United States | Recruiting |
| Asthma & Allergy Associates - Colorado Springs | Colorado Springs, Colorado, United States | Recruiting |
| AMR Clinical | Doral, Florida, United States | Recruiting |
| Renstar Medical Research | Ocala, Florida, United States | Recruiting |
| Avanza Medical Research Center | Pensacola, Florida, United States | Recruiting |
| USF Health | Tampa, Florida, United States | Recruiting |
| Axis Clinical Trials - Westchester | Westchester, Illinois, United States | Recruiting |
| Allergy & Asthma Specialists, P.S.C. | Owensboro, Kentucky, United States | Recruiting |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Recruiting |
+ 109 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07219173